Top Pharmaceuticals companies in Poland by EBITDA Margin

This ranking features the top 21 Pharmaceuticals companies in Poland ranked by EBITDA Margin, averaging a EBITDA Margin of -838,740.48%, for January 15, 2025.

Poland

Pharmaceuticals

#	Name	EBITDA Margin	Reported Date	Stock Price	Change	Country
1	Pharmena S.A. 1 PHR.WA	361.41%	Dec. 31, 2023	USD 1.01	1.23%	Poland
2	Mabion S.A. 2 MAB.WA	38.45%	Dec. 31, 2023	USD 2.34	1.69%	Poland
3	Selvita S.A. 3 SLV.WA	36.20%	Dec. 31, 2023	USD 11.11	-3.75%	Poland
4	Synthaverse S.A. 4 SVE.WA	25.41%	Dec. 31, 2023	USD 1.05	-1.52%	Poland
5	BIOTON S.A. 5 BIO.WA	24.17%	Dec. 31, 2023	USD 0.77	0.43%	Poland
6	Synektik Spólka Akcyjna 6 SNT.WA	20.08%	Sept. 30, 2024	USD 50.91	0.74%	Poland
7	Celon Pharma S.A. 7 CLN.WA	19.90%	Dec. 31, 2023	USD 6.09	-0.44%	Poland
8	Centrum Medyczne ENEL-MED S.A. 8 ENE.WA	14.73%	Dec. 31, 2023	USD 4.92	2.76%	Poland
9	BioMaxima S.A. 9 BMX.WA	7.02%	Dec. 31, 2023	USD 2.77	1.63%	Poland
10	Mercator Medical S.A. 10 MRC.WA	4.14%	Dec. 31, 2023	USD 12.79	0.55%	Poland
11	NEUCA S.A. 11 NEU.WA	3.40%	Dec. 31, 2023	USD 204.85	1.34%	Poland
12	Ryvu Therapeutics S.A. 12 RVU.WA	-172.95%	Dec. 31, 2023	USD 7.78	-9.75%	Poland
13	M.W. Trade SA 13 MWT.WA	-409.42%	Dec. 31, 2023	USD 0.71	0.06%	Poland
14	Captor Therapeutics Spolka Akcyjna 14 CTX.WA	-490.60%	Dec. 31, 2023	USD 10.54	0.97%	Poland
15	Poltreg S.A. 15 PTG.WA	-833.38%	Dec. 31, 2023	USD 9.29	-3.28%	Poland
16	Medinice S.A. 16 ICE.WA	-2,100.89%	Dec. 31, 2023	USD 1.85	-0.17%	Poland
17	Scope Fluidics S.A. 17 SCP.WA	-3,342.44%	Dec. 31, 2023	USD 40.10	-0.57%	Poland
18	Pure Biologics Spólka Akcyjna 18 PUR.WA	-27,449.47%	Dec. 31, 2023	USD 3.73	-0.03%	Poland
19	NanoGroup S.A. 19 NNG.WA	-389,809.76%	Dec. 31, 2023	USD 0.79	1.05%	Poland
20	Genomtec S.A. 20 GMT.WA	-775,600.00%	Dec. 31, 2023	USD 1.74	1.31%	Poland
21	Molecure S.A. 21 MOC.WA	-16,413,896.00%	Dec. 31, 2023	USD 2.23	1.07%	Poland

Frequently Asked Questions

Which Pharmaceuticals company in Poland has the highest EBITDA Margin ?

The Pharmaceuticals company in Poland with the highest EBITDA Margin is Pharmena S.A. (Warsaw Stock Exchange: PHR.WA) at 361.41%.
Which Pharmaceuticals company in Poland has the lowest EBITDA Margin ?

The Pharmaceuticals company in Poland with the lowest EBITDA Margin is Molecure S.A. (Warsaw Stock Exchange: MOC.WA) at -16,413,896.00%.

What are the top 10 Pharmaceuticals companies in Poland by EBITDA Margin ?

The top 10 Pharmaceuticals companies in Poland by EBITDA Margin are Pharmena S.A., Mabion S.A., Selvita S.A., Synthaverse S.A., BIOTON S.A., Synektik Spólka Akcyjna, Celon Pharma S.A., Centrum Medyczne ENEL-MED S.A., BioMaxima S.A. and Mercator Medical S.A..
What are the bottom 10 Pharmaceuticals companies in Poland by EBITDA Margin ?

The bottom 10 Pharmaceuticals companies in Poland by EBITDA Margin are Molecure S.A., Genomtec S.A., NanoGroup S.A., Pure Biologics Spólka Akcyjna, Scope Fluidics S.A., Medinice S.A., Poltreg S.A., Captor Therapeutics Spolka Akcyjna, M.W. Trade SA and Ryvu Therapeutics S.A..